🔗 Share this article

The top legal official in Texas Paxton is suing the producers of acetaminophen, alleging the companies withheld safety concerns that the drug created to pediatric cognitive development.

The lawsuit arrives four weeks after President Donald Trump advocated an unproven link between consuming acetaminophen - alternatively called paracetamol - throughout gestation and autism spectrum disorder in young ones.

The attorney general is taking legal action against J&J, which once produced the medication, the only pain reliever recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "betrayed America by profiting off of discomfort and marketing drugs ignoring the risks."

The manufacturer states there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking countless individuals to line their pockets," the attorney general, a Republican, said.

The company said in a statement that it was "deeply concerned by the spread of false claims on the reliability of acetaminophen and the likely effects that could have on the health of women and children in America."

On its online platform, the company also stated it had "regularly reviewed the pertinent research and there is lacking reliable evidence that indicates a established connection between using acetaminophen and autism."

Associations representing physicians and health professionals concur.

The American College of Obstetricians and Gynecologists has declared paracetamol - the main ingredient in Tylenol - is a restricted selection for pregnant women to manage pain and elevated temperature, which can present major wellness concerns if ignored.

"In over twenty years of investigation on the utilization of paracetamol in gestation, no reliable research has definitively established that the usage of paracetamol in any period of gestation results in neurological conditions in young ones," the group stated.

The court filing mentions latest statements from the previous government in claiming the medication is allegedly unsafe.

In recent weeks, the former president raised alarms from public health officials when he told pregnant women to "struggle intensely" not to consume Tylenol when ill.

Federal regulators then published an announcement that physicians should think about restricting the use of Tylenol, while also declaring that "a causal relationship" between the medication and autism in minors has not been established.

Health Secretary RFK Jr, who oversees the Food and Drug Administration, had promised in April to conduct "extensive scientific investigation" that would establish the cause of autism spectrum disorder in a short period.

But specialists cautioned that discovering a unique factor of autism - believed by scientists to be the outcome of a complicated interplay of inherited and environmental factors - would not be simple.

Autism spectrum disorder is a type of lifelong neurodivergence and condition that affects how individuals perceive and engage with the environment, and is recognized using physician assessments.

In his court filing, Paxton - who supports Trump who is running for the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "remove any promotional materials" that claims Tylenol is reliable for pregnant women.

This legal action mirrors the grievances of a collection of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in two years ago.

Judicial authorities dismissed the legal action, declaring research from the parents' expert witnesses was not conclusive.